• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH); CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, EXCLUDING MUELLER HINTON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH); CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, EXCLUDING MUELLER HINTON Back to Search Results
Catalog Number 252353
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/06/2023
Event Type  malfunction  
Manufacturer Narrative
The manufacturing location for this product is fukushima.This site is an oem manufacturing site.Therefore, bd corporate headquarters in sparks, md has been listed in sections d.3.And g.1.And the sparks fda registration number has been used for the manufacture report number d.4.Medical device expiration date: unknown h.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd bbl¿ chromagar® mrsa ii 100mm (20 each) there was insufficient growth of one sample.No patient impact reported.The following information was provided by the initial reporter: "this is a report about an issue that mrsa does not grow from the sample.According to the customer's report, the bacteria which result was positive by blood cultivation and identified as mrsa by maldi does not grow.It slightly grows when spreading the sample on the blood agar, making an isolation culture, and spreading on the mrsa media.Were these patient samples? yes.- if so - were any erroneous results reported to healthcare provider? no.- if yes - were any patients treated based on the erroneous results? na.- any other patient impact >>no patient impact".
 
Event Description
It was reported that while using bd bbl¿ chromagar® mrsa ii 100mm (20 each) there was insufficient growth of one sample.No patient impact reported.The following information was provided by the initial reporter: "this is a report about an issue that mrsa does not grow from the sample.According to the customer's report, the bacteria which result was positive by blood cultivation and identified as mrsa by maldi does not grow.It slightly grows when spreading the sample on the blood agar, making an isolation culture, and spreading on the mrsa media.Were these patient samples? yes.If so - were any erroneous results reported to healthcare provider? no.If yes - were any patients treated based on the erroneous results? na.Any other patient impact no patient impact.".
 
Manufacturer Narrative
H.6.Investigation summary: 252353 #3185591 we couldn't confirm this issue as a report because no photo and returned sample.No issue in retention for performance and dhr.No trend.We will continue to monitor this lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ CHROMAGAR® MRSA II 100MM (20 EACH)
Type of Device
CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, EXCLUDING MUELLER HINTON
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17839467
MDR Text Key324530994
Report Number1119779-2023-01035
Device Sequence Number1
Product Code JSO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K092767
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number252353
Device Lot Number3185591
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-